14-3-3 theta Antikörper (AA 31-130) (Cy5)
Kurzübersicht für 14-3-3 theta Antikörper (AA 31-130) (Cy5) (ABIN1704158)
Target
Alle 14-3-3 theta (YWHAQ) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-130
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Dog,Cow,Sheep,Pig
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human 14-3-3 Tau
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- 14-3-3 theta (YWHAQ)
-
Andere Bezeichnung
- 14-3-3 Tau
-
Hintergrund
-
Synonyms: 14 3 3 protein T cell, 14 3 3 protein tau, 14 3 3 protein theta, 14 3 3 tau, 14 3 3 theta, 14-3-3 protein T-cell, 14-3-3 protein tau, 14-3-3 protein theta, 1433T_HUMAN, 1C5, HS1, KCIP1, Protein HS1, Protein kinase C inhibitor protein 1, Protein tau, tyr3/trp5 monooxygenase activation protein, theta, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, theta polypeptide, YWHAQ.
Background: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1.This antibody is reactive with 14-3-3 Alpha/Beta/Gamma/Delta/Epsilon.
-
Gen-ID
- 10971
-
Pathways
- Apoptose, Myometrial Relaxation and Contraction
Target
-